Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Perspective Therapeutics (CATX – Research Report), Axsome Therapeutics (AXSM – Research Report) and HCA Healthcare (HCA – Research Report).

Perspective Therapeutics (CATX)

Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Perspective Therapeutics yesterday and set a price target of $6.00. The company’s shares closed last Friday at $4.01, close to its 52-week low of $2.70.

According to TipRanks.com, Stranahan has 0 stars on 0-5 stars ranking scale with an average return of -10.2% and a 36.1% success rate. Stranahan covers the Healthcare sector, focusing on stocks such as Day One Biopharmaceuticals, Recursion Pharmaceuticals, and Springworks Therapeutics.

Currently, the analyst consensus on Perspective Therapeutics is a Strong Buy with an average price target of $14.83.

HCA Healthcare (HCA)

Morgan Stanley analyst Craig Hettenbach maintained a Hold rating on HCA Healthcare yesterday and set a price target of $355.00. The company’s shares closed last Friday at $313.07.

According to TipRanks.com, Hettenbach is ranked #1917 out of 9313 analysts.

Currently, the analyst consensus on HCA Healthcare is a Moderate Buy with an average price target of $381.93, representing a 17.9% upside. In a report issued on January 14, Bernstein also maintained a Hold rating on the stock with a $331.00 price target.